USPTO 2015–2025 USPTO PatentsView US Corporation

Encapsys, Llc

USPTO PatentsView assignee record - 24 granted patents across 31 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01J (CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS).

24
Total patents granted
31
CPC technology areas
21.1
Avg claims per patent
-43%
5-year grant velocity

The verdict

According to USPTO PatentsView, Encapsys ranks #12,428 of 50,000 tracked US assignees by granted-patent volume, with 24 patents across 31 technology areas.

#12,428
of 50,000 US assignees by volume
Top 13%
by Innovation Score (50.1/100)
21.1
avg claims per patent
-43%
grant velocity, last 5 yrs

Portfolio overview

Encapsys, Llc has been granted 24 US utility patents between 2015 and 2025, placing Encapsys, Llc at #12,428 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 31 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.1 claims per patent with primary concentration in B01J (CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS). As a US Corporation, Encapsys, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Encapsys sits between Dutch Clips Llc (24 patents, rank #12,422) and Exogenesis Corporation (24 patents, rank #12,430) - the closest US assignees by grant volume. The composite Innovation Score of 50.1/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 8 grants, compared with 14 in the 2015–2019 window, a -43% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Encapsys, Llc's 21.1 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 31 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Who files at Encapsys's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Encapsys holds 24 patents at rank #12,426, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Encapsys

By rank, the assignees closest to #12,426 in granted patent volume.

Leaders in B01J (Chemical OR Physical Processes)

Other assignees with the most granted patents in Encapsys's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Encapsys, neither rank-band nor same-CPC leaders (those blocks stay above).

Encapsys's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 13% higher than 87% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 201520162017201820192021202320242025 2
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Encapsys, Llc patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 8.3%
2016 1 4.2%
2017 4 16.7%
2018 1 4.2%
2019 6 25.0%
2021 1 4.2%
2023 1 4.2%
2024 6 25.0%
2025partial year 2 8.3%

Which technologies does Encapsys, Llc patent most?

Top 15 of 31 technology areas

Grant record at a glance

Portfolio Volume 24 grants
CPC subclasses 31
Avg. claims / grant 21.1
Velocity -43%

Historical grant data only; it does not rate legal strength or current strategy.

Where it ranks

Overall rank by patents

#12,428

of 50,000 tracked assignees

Innovation Score

50.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

Where does Encapsys, Llc rank among US patent assignees?
According to USPTO PatentsView (2015–2025 granted utility patents), Encapsys, Llc ranks #12,428 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.
How many patents does Encapsys, Llc hold?
Encapsys, Llc holds 24 US utility patents granted between 2015 and 2025, spanning 31 technology areas.
What is Encapsys, Llc's Innovation Score?
Encapsys, Llc has an Innovation Score of 50.1 out of 100 (top 13% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Encapsys, Llc focus on?
Encapsys, Llc's top technology area is B01J (CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS) with 19 patents. Grants appear in 31 CPC subclasses total.
Is Encapsys, Llc's patent grant rate increasing or decreasing?
Encapsys, Llc's recent grant velocity is -43% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.
What does claim depth mean for Encapsys, Llc's patents?
Encapsys, Llc's patents average 21.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.
How is the Encapsys, Llc patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Encapsys's 24 grants land it in the top 13% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Encapsys ranks #12,428 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in B01J - see who else leads that technology area. B01J leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.